Your browser is no longer supported. Please, upgrade your browser.
InterCure Ltd.
Index- P/E- EPS (ttm)- Insider Own64.86% Shs Outstand53.62M Perf Week3.89%
Market Cap401.05M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float24.83M Perf Month4.76%
Income- PEG- EPS next Q- Inst Own5.58% Short Float0.17% Perf Quarter-0.80%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.30 Perf Half Y-2.86%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year46.19%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range2.01 - 12.72 Perf YTD29.32%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-41.22% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low272.14% ATR0.34
Employees75 Current Ratio- Sales Q/Q304.40% Oper. Margin- RSI (14)52.11 Volatility3.56% 4.60%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.16 Prev Close7.34
ShortableYes LT Debt/Eq- EarningsNov 16 BMO Payout- Avg Volume138.75K Price7.48
Recom- SMA20-1.51% SMA504.21% SMA2004.89% Volume22,257 Change1.91%
Dec-02-21 08:15AM  
Nov-29-21 08:30AM  
Nov-15-21 07:00PM  
Nov-11-21 08:00AM  
Oct-29-21 04:34PM  
Oct-25-21 01:30AM  
Oct-13-21 12:15PM  
Oct-12-21 02:00AM  
Sep-15-21 08:59AM  
Sep-13-21 08:43AM  
Sep-08-21 09:57AM  
Sep-03-21 09:29AM  
Sep-02-21 09:39AM  
Sep-01-21 01:00AM  
InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.